US 10415038
Compounds and methods for modulating TMPRSS6 expression
granted A61KA61K47/549A61P
Quick answer
US patent 10415038 (Compounds and methods for modulating TMPRSS6 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K47/549, A61P, A61P7/00, A61P7/06